07:00 , Oct 5, 2009 |  BC Week In Review  |  Clinical News

RotaShield: Phase II started

The non-profit foundation began a double-blind, placebo-controlled, Ghanaian Phase II trial to evaluate 2 oral doses of RotaShield given once soon after birth and again at 60 days old in 1,051 infants. RotaShield was approved...
07:00 , Apr 3, 2006 |  BC Week In Review  |  Company News

BIOVIRx, Impfstoffwerk Dessau-Tornau GmbH deal

IDT will manufacture Biovirx's RotaShield oral rotavirus vaccine. Biovirx licensed RotaShield from NIH in 2004 (see BioCentury, May 10, 2004). Biovirx Inc. , Minneapolis, Minn.   Impfstoffwerk Dessau-Tornau GmbH , Tornau, Germany   Business: Biomanufacturing,...
07:00 , Oct 17, 2005 |  BioCentury  |  Strategy

Vaccines getting hot

For decades, infectious disease vaccines were viewed as unattractive products with low margins, small markets and liability issues. But fears of global influenza and avian flu pandemics, the SARS outbreak a few years ago and...
07:00 , May 10, 2004 |  BC Week In Review  |  Company News

BIOVIRx, National Institutes of Health deal

Biovirx received a license to RotaShield , an oral rotavirus vaccine discovered at NIH. RotaShield was approved by FDA in 1998 but was withdrawn from the market in 1999 by Wyeth (WYE, Madison, N.J.) because...
07:00 , May 10, 2004 |  BioCentury  |  Finance

Ebb & Flow

ImClone (IMCL) boosted its war chest by half a billion dollars last week, thanks to a bumped-up convertible note deal. What's more, the company does not expect that it will have to earmark the proceeds...
07:00 , May 10, 2004 |  BioCentury  |  Finance

Midwest work ethic

Midwest work ethic Company Location Round Proposed amt ($M) Focus Notes APT St. Louis, Mo. B $8.0 Stroke Hopes the proceeds will provide about two years of runway and allow it to submit INDs for...
07:00 , May 4, 2004 |  BC Extra  |  Company News

NIH licenses rotavirus vaccine to Biovirx

Biovirx (Shoreview, Minn.) received a license to RotaShield , an oral rotavirus vaccine discovered at NIH. RotaShield was approved by FDA in 1998 but was withdrawn from the market in 1999 because of a possible...